Integral Diagnostics Ltd. (AU:IDX) has released an update.
Integral Diagnostics Ltd. announced a significant increase in performance rights for CEO Ian Kadish, as part of the company’s Equity Incentive Plan approved by shareholders. The issuance adds 327,566 rights, bringing Kadish’s total to 975,498 performance rights, reflecting a strategic move to align executive interests with company performance.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
